Relapsing Multiple Sclerosis: Clinical Trials

1 trial for Relapsing Multiple Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Withdrawn 1

Follow Relapsing Multiple Sclerosis: new trials by email Literature Review of Relapsing Multiple Sclerosis trials Research Report on Relapsing Multiple Sclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy
Interferon Beta, BIIB017 (Peginterferon beta-1a) - Relapsing Multiple Sclerosis
Phase 4WithdrawnBiogen2014-10-012014-11-17

Interventions

Interferon beta-1a (1)  ·  Interferon beta-1b (1)  ·  Interferon-beta (1)  ·  peginterferon beta-1a (1)

Sponsors

Biogen (1)